Abstract
Priapism is a prolonged, persistent, and painful penile erection unassociated with sexual interest or stimulation, which affects a large percentage of male sickle cell disease (SCD) patients. It manifests either as an acute, severe event, or as recurrent, stuttering priapism, with very limited therapeutic options. Untreated priapism can cause irreversible erectile dysfunction and surgical treatment remains the only option for severe cases. The mechanisms that contribute to the development of sickle cell disease-associated priapism are not fully understood, precluding efficacious pharmacological approaches. In this chapter, we review the physiology of penile erection, definitions of priapism, and summarize current knowledge of the pathophysiology underlying SCD-associated priapism. We discuss current and future possible therapeutic interventions, with emphasis on dysregulated signaling pathways that contribute to the development of this complication, such as the nitric oxide/cyclic guanosine monophosphate system and the RhoA/ROCK system, as well as the role of adenosine, opiorphins, and androgens in the pathogenesis of priapism.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abern MR, Levine LA (2009) Ketoconazole and prednisone to prevent recurrent ischemic priapism. J Urol 182(4):1401–1406
Adeyoju AB, Olujohungbe AB, Morris J et al (2002) Priapism in sickle-cell disease; incidence, risk factors and complications – an international multicentre study. BJU Int 90(9):898–902
Andersson KE (2001a) Pharmacology of erectile function and dysfunction. Urol Clin North Am 28(2):233–247
Andersson KE (2001b) Pharmacology of penile erection. Pharmacol Rev 53(3):417–450
Anele UA, Burnett AL (2015) Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors. J Sex Med 12(3):713–719
Anele UA, Morrison BF, Burnett AL (2015) Molecular pathophysiology of priapism: emerging targets. Curr Drug Targets 16:474–483
Bivalacqua TJ, Burnett AL (2006) Priapism: new concepts in the pathophysiology and new treatment strategies. Curr Urol Rep 7(6):497–502
Bivalacqua TJ, Champion HC, Usta MF et al (2004) RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction. Proc Natl Acad Sci U S A 101(24):9121–9126
Bivalacqua TJ, Liu T, Musicki B, Champion HC, Burnett AL (2007) Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis. Eur Urol 51(6):1732–1740
Bivalacqua TJ, Musicki B, Hsu LL et al (2009) Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism. J Sex Med 6(9):2494–2504
Bivalacqua TJ, Ross AE, Strong TD et al (2010) Attenuated RhoA/Rho-kinase signaling in penis of transgenic sickle cell mice. Urology 76(2):510.e517–e512
Bivalacqua TJ, Musicki B, Kutlu O, Burnett AL (2012) New insights into the pathophysiology of sickle cell disease-associated priapism. J Sex Med 9(1):79–87
Bivalacqua TJ, Musicki B, Hsu LL et al (2013) Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress. PLoS One 8(7), e68028
Broderick GA (2012) Priapism and sickle-cell anemia: diagnosis and nonsurgical therapy. J Sex Med 9(1):88–103
Broderick GA, Kadioglu A, Bivalacqua TJ et al (2010) Priapism: pathogenesis, epidemiology, and management. J Sex Med 7(1 Pt 2):476–500
Burnett AL (2004) Novel nitric oxide signaling mechanisms regulate the erectile response. Int J Impot Res 16(Suppl 1):S15–S19
Burnett AL, Musicki B (2005) The nitric oxide signaling pathway in the penis. Curr Pharm Des 11(31):3987–3994
Cellek S (2000) Nitrergic-noradrenergic interaction in penile erection: a new insight into erectile dysfunction. Drugs Today (Barc) 36(2–3):135–146
Champion HC, Bivalacqua TJ, Takimoto E, Kass DA, Burnett AL (2005) Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci U S A 102(5):1661–1666
Chow K, Payne S (2008) The pharmacological management of intermittent priapismic states. BJU Int 102(11):1515–1521
Chua RG, Calenda G, Zhang X et al (2009) Testosterone regulates erectile function and Vcsa1 expression in the corpora of rats. Mol Cell Endocrinol 303(1-2):67–73
Claudino MA, Fertrin KY (2012) Sickling cells, cyclic nucleotides, and protein kinases: the pathophysiology of urogenital disorders in sickle cell anemia. Anemia 2012:723520
Claudino MA, Franco-Penteado CF, Corat MA et al (2009) Increased cavernosal relaxations in sickle cell mice priapism are associated with alterations in the NO-cGMP signaling pathway. J Sex Med 6(8):2187–2196
Colgan SP, Eltzschig HK, Eckle T, Thompson LF (2006) Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal 2(2):351–360
Corbin JD (2004) Mechanisms of action of PDE5 inhibition in erectile dysfunction. Int J Impot Res 16(Suppl 1):S4–S7
Crane GM, Bennett NE (2011) Priapism in sickle cell anemia: emerging mechanistic understanding and better preventative strategies. Anemia 2011, 297364
Davies KP (2009) The role of opiorphins (endogenous neutral endopeptidase inhibitors) in urogenital smooth muscle biology. J Sex Med 6(Suppl 3):286–291
Diggs LW, Ching RE (1934) Pathology of sickle cell anemia. Southern Med J 27:839–845
El-Bahnasawy MS, Dawood A, Farouk A (2002) Low-flow priapism: risk factors for erectile dysfunction. BJU Int 89(3):285–290
Faria M, Magalhães-Cardoso T, Lafuente-de-Carvalho JM, Correia-de-Sá P (2006) Corpus cavernosum from men with vasculogenic impotence is partially resistant to adenosine relaxation due to endothelial A(2B) receptor dysfunction. J Pharmacol Exp Ther 319(1):405–413
Filippi S, Marini M, Vannelli GB et al (2003) Effects of hypoxia on endothelin-1 sensitivity in the corpus cavernosum. Mol Hum Reprod 9(12):765–774
Förstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33(7):829–837, 837a–837d
Fowler JE, Koshy M, Strub M, Chinn SK (1991) Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae. J Urol 145(1):65–68
Fu S, Tar MT, Melman A, Davies KP (2014) Opiorphin is a master regulator of the hypoxic response in corporal smooth muscle cells. FASEB J 28(8):3633–3644
Furtado PS, Costa MP, Ribeiro do Prado Valladares F et al (2012) The prevalence of priapism in children and adolescents with sickle cell disease in Brazil. Int J Hematol 95(6):648–651
Giuliano F (2011) Neurophysiology of erection and ejaculation. J Sex Med 8(Suppl 4):310–315
Gopal VK, Francis SH, Corbin JD (2001) Allosteric sites of phosphodiesterase-5 (PDE5). A potential role in negative feedback regulation of cGMP signaling in corpus cavernosum. Eur J Biochem 268(11):3304–3312
Gratzke C, Strong TD, Gebska MA et al (2010) Activated RhoA/Rho kinase impairs erectile function after cavernous nerve injury in rats. J Urol 184(5):2197–2204
Hershfield MS (1995) PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years. Clin Immunol Immunopathol 76(3 Pt 2):S228–S232
Hsu LL, Champion HC, Campbell-Lee SA et al (2007) Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood 109(7): 3088–3098
Hurt KJ, Musicki B, Palese MA et al (2002) Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection. Proc Natl Acad Sci U S A 99(6):4061–4066
Hurt KJ, Sezen SF, Lagoda GF et al (2012) Cyclic AMP-dependent phosphorylation of neuronal nitric oxide synthase mediates penile erection. Proc Natl Acad Sci U S A 109(41):16624–16629
Isidori AM, Buvat J, Corona G et al (2014) A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. Eur Urol 65(1):99–112
Kanika ND, Tar M, Tong Y et al (2009) The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway. Am J Physiol Cell Physiol 297(4):C916–C927
Kanika ND, Melman A, Davies KP (2010) Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue. Int J Impot Res 22(6):363–373
Kato GJ, Gladwin MT, Steinberg MH (2007) Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 21(1):37–47
Kietadisorn R, Juni RP, Moens AL (2012) Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities. Am J Physiol Endocrinol Metab 302(5):E481–E495
Lagoda G, Sezen SF, Cabrini MR, Musicki B, Burnett AL (2013) Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis. J Urol 189(2):762–768
Liaw RL, Srilatha B, Adaikan PG (2011) Effects of hydrogen sulfide on erectile function and its possible mechanism(s) of action. J Sex Med 8(7):1853–1864
Lin G, Xin ZC, Lue TF, Lin CS (2003) Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism. J Urol 170(2 Pt 2):S15–S18; discussion S19
Lin CS, Lin G, Lue TF (2005) Cyclic nucleotide signaling in cavernous smooth muscle. J Sex Med 2(4):478–491
Linder AE, Webb RC, Mills TM et al (2005) Rho-kinase and RGS-containing RhoGEFs as molecular targets for the treatment of erectile dysfunction. Curr Pharm Des 11(31):4029–4040
Lionnet F, Hammoudi N, Stojanovic KS et al (2012) Hemoglobin sickle cell disease complications: a clinical study of 179 cases. Haematologica 97(8):1136–1141
Lucas KA, Pitari GM, Kazerounian S et al (2000) Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52(3):375–414
Lue TF (2000) Erectile dysfunction. N Engl J Med 342(24):1802–1813
Mantadakis E, Cavender JD, Rogers ZR, Ewalt DH, Buchanan GR (1999) Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol 21(6):518–522
Mi T, Abbasi S, Zhang H et al (2008) Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J Clin Invest 118(4):1491–1501
Mills TM, Lewis RW, Wingard CJ et al (2003) Vasoconstriction, RhoA/Rho-kinase and the erectile response. Int J Impot Res 15(Suppl 5):S20–S24
Montague DK, Jarow J, Broderick GA et al (2003) American Urological Association guideline on the management of priapism. J Urol 170(4 Pt 1):1318–1324
Morelli A, Filippi S, Mancina R et al (2004) Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology 145(5):2253–2263
Morrison BF, Burnett AL (2012) Stuttering priapism: insights into pathogenesis and management. Curr Urol Rep 13(4):268–276
Morrison BF, Reid M, Madden W, Burnett AL (2013) Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report. Andrology 1(4):576–582
Morrison BF, Anele UA, Reid ME et al (2015) Is testosterone deficiency a possible risk factor for priapism associated with sickle-cell disease? Int Urol Nephrol 47(1):47–52
Muneer A, Minhas S, Arya M, Ralph DJ (2008) Stuttering priapism – a review of the therapeutic options. Int J Clin Pract 62(8):1265–1270
Musicki B, Ross AE, Champion HC, Burnett AL, Bivalacqua TJ (2009) Posttranslational modification of constitutive nitric oxide synthase in the penis. J Androl 30(4):352–362
Musicki B, Liu T, Sezen SF, Burnett AL (2012) Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis. J Sex Med 9(8):1980–1987
Musicki B, Bivalacqua TJ, Champion HC, Burnett AL (2014) Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis. J Sex Med 11(2): 424–430
Nangle MR, Cotter MA, Cameron NE (2004) An in vitro investigation of aorta and corpus cavernosum from eNOS and nNOS gene-deficient mice. Pflugers Arch 448(2):139–145
Ning C, Wen J, Zhang Y et al (2014) Excess adenosine A2B receptor signaling contributes to priapism through HIF-1α mediated reduction of PDE5 gene expression. FASEB J 28(6):2725–2735
Olsson RA, Pearson JD (1990) Cardiovascular purinoceptors. Physiol Rev 70(3):761–845
Osegbe DN, Akinyanju OO (1987) Testicular dysfunction in men with sickle cell disease. Postgrad Med J 63(736):95–98
Parshad O, Stevens MC, Preece MA, Thomas PW, Serjeant GR (1994) The mechanism of low testosterone levels in homozygous sickle-cell disease. West Indian Med J 43(1):12–14
Phatarpekar PV, Wen J, Xia Y (2010) Role of adenosine signaling in penile erection and erectile disorders. J Sex Med 7(11):3553–3564
Prieto D (2008) Physiological regulation of penile arteries and veins. Int J Impot Res 20(1):17–29
Priviero FB, Jin LM, Ying Z, Teixeira CE, Webb RC (2010) Up-regulation of the RhoA/Rho-kinase signaling pathway in corpus cavernosum from endothelial nitric-oxide synthase (NOS), but not neuronal NOS, null mice. J Pharmacol Exp Ther 333(1):184–192
Rees RW, Ziessen T, Ralph DJ et al (2002) Human and rabbit cavernosal smooth muscle cells express Rho-kinase. Int J Impot Res 14(1):1–7
Reilly CM, Lewis RW, Stopper VS, Mills TM (1997) Androgenic maintenance of the rat erectile response via a non-nitric-oxide-dependent pathway. J Androl 18(6):588–594
Riento K, Ridley AJ (2003) Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 4(6):446–456
Salonia A, Eardley I, Giuliano F et al (2014) European Association of Urology guidelines on priapism. Eur Urol 65(2):480–489
Slayton W, Kedar A, Schatz D (1995) Testosterone induced priapism in two adolescents with sickle cell disease. J Pediatr Endocrinol Metab 8(3):199–203
Sobrevia L, Mann GE (1997) Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia. Exp Physiol 82(3):423–452
Somlyo AP, Somlyo AV (2003) Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83(4):1325–1358
Spycher MA, Hauri D (1986) The ultrastructure of the erectile tissue in priapism. J Urol 135(1): 142–147
Srilatha B, Adaikan PG, Li L, Moore PK (2007) Hydrogen sulphide: a novel endogenous gasotransmitter facilitates erectile function. J Sex Med 4(5):1304–1311
Tager AM, LaCamera P, Shea BS et al (2008) The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 14(1):45–54
Tarry WF, Duckett JW, Snyder HM (1987) Urological complications of sickle cell disease in a pediatric population. J Urol 138(3):592–594
Tong Y, Tiplitsky SI, Tar M, Melman A, Davies KP (2008) Transcription of G-protein coupled receptors in corporeal smooth muscle is regulated by the endogenous neutral endopeptidase inhibitor sialorphin. J Urol 180(2):760–766
Tostes RC, Giachini FR, Carneiro FS et al (2007) Determination of adenosine effects and adenosine receptors in murine corpus cavernosum. J Pharmacol Exp Ther 322(2):678–685
Traish A, Kim N (2005) The physiological role of androgens in penile erection: regulation of corpus cavernosum structure and function. J Sex Med 2(6):759–770
Traish AM, Park K, Dhir V et al (1999) Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology 140(4):1861–1868
Traish AM, Goldstein I, Kim NN (2007) Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol 52(1):54–70
Traish AM, Miner MM, Morgentaler A, Zitzmann M (2011) Testosterone deficiency. Am J Med 124(7):578–587
Villalba N, Stankevicius E, Garcia-Sacristán A, Simonsen U, Prieto D (2007) Contribution of both Ca2+ entry and Ca2+ sensitization to the alpha1-adrenergic vasoconstriction of rat penile small arteries. Am J Physiol Heart Circ Physiol 292(2):H1157–H1169
Villalba N, Stankevicius E, Simonsen U, Prieto D (2008) Rho kinase is involved in Ca2+ entry of rat penile small arteries. Am J Physiol Heart Circ Physiol 294(4):H1923–H1932
Wang H, Eto M, Steers WD, Somlyo AP, Somlyo AV (2002) RhoA-mediated Ca2+ sensitization in erectile function. J Biol Chem 277(34):30614–30621
Webb RC (2003) Smooth muscle contraction and relaxation. Adv Physiol Educ 27(1-4):201–206
Wen J, Jiang X, Dai Y et al (2010) Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling. FASEB J 24(3):740–749
Wettschureck N, Offermanns S (2002) Rho/Rho-kinase mediated signaling in physiology and pathophysiology. J Mol Med (Berl) 80(10):629–638
Wisner A, Dufour E, Messaoudi M et al (2006) Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways. Proc Natl Acad Sci U S A 103(47):17979–17984
Wood KC, Hebbel RP, Granger DN (2005) Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice. FASEB J 19(8):989–991
Wood KC, Hebbel RP, Lefer DJ, Granger DN (2006) Critical role of endothelial cell-derived nitric oxide synthase in sickle cell disease-induced microvascular dysfunction. Free Radic Biol Med 40(8):1443–1453
Zhang Y, Dai Y, Wen J et al (2011) Detrimental effects of adenosine signaling in sickle cell disease. Nat Med 17(1):79–86
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Claudino, M.A., Franco Penteado, C.F., Fertrin, K.Y. (2016). Priapism in Sickle Cell Disease: New Aspects of Pathophysiology. In: Costa, F., Conran, N. (eds) Sickle Cell Anemia. Springer, Cham. https://doi.org/10.1007/978-3-319-06713-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-06713-1_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-06712-4
Online ISBN: 978-3-319-06713-1
eBook Packages: MedicineMedicine (R0)